Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Trastornos del movimiento Movement disorders 116 artículos Viendo del 1 al 40 de 116 artículos
Pub MED

[A cross-sectional study of the association of movement disorders, constipation and sleep disturbances among elderly in China].NUEVO

Wang ZH, Wang LH, Li YC, Qi SG, Wang LM.
Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Sep;47(9):806-10. Chinese.
Pub MED

[Characteristic movement disorders in myasthenic eye muscle paralysis].NUEVO

Schmidt D.
Ophthalmologe. 2013 Dec;110(12):1201-2. doi: 10.1007/s00347-013-2996-6. German. No abstract available.
Pub MED

Movement disorders in multiple sclerosis.NUEVO

Oakes PK, Srivatsal SR, Davis MY, Samii A.
Phys Med Rehabil Clin N Am. 2013 Nov;24(4):639-51. doi: 10.1016/j.pmr.2013.06.003. Review.
Pub MED

Clozapine and tardive movement disorders: a review.NUEVO

Hazari N, Kate N, Grover S.
Asian J Psychiatr. 2013 Dec;6(6):439-51. doi: 10.1016/j.ajp.2013.08.067. Review.
Pub MED

[Role of neurosurgical management in movement disorders other than Parkinson disease].NUEVO

Taira T.
Rinsho Shinkeigaku. 2013;53(11):966-8. Review. Japanese.
Pub MED

[Update on deep brain stimulation for movement disorders].NUEVO

Umemura A, Oyama G, Shimo Y, Hattori N.
Rinsho Shinkeigaku. 2013;53(11):911-4. Review. Japanese.
Pub MED

[Clinical treatment of spasticity--spastic movement disorders].NUEVO

Dietz V.
Nervenarzt. 2013 Dec;84(12):1508-11. doi: 10.1007/s00115-013-3933-2. Review. German.
Pub MED

Movement disorders: Indian scenario: a clinico-genetic review.NUEVO

Das SK, Ghosh B, Das G, Biswas A, Ray J.
Neurol India. 2013 Sep-Oct;61(5):457-66. doi: 10.4103/0028-3886.121908. Review.
Pub MED

Tai Ji Quan Exercise for People with Parkinson's Disease and Other Neurodegenerative Movement Disorders.NUEVO

Li F.
Int J Integr Med. 2013;1(4). doi: 10.5772/56243.
Pub MED

Very early pattern of movement disorders in sepiapterin reductase deficiency.NUEVO

Leuzzi V, Carducci C, Tolve M, Giannini MT, Angeloni A, Carducci C.
Neurology. 2013 Dec 10;81(24):2141-2. doi: 10.1212/01.wnl.0000437299.51312.5f. No abstract available.
Pub MED

Autoantibody-associated movement disorders.NUEVO

Mohammad SS, Ramanathan S, Brilot F, Dale RC.
Neuropediatrics. 2013 Dec;44(6):336-45. doi: 10.1055/s-0033-1358603. Review.
Pub MED

Movement Disorders Among Adult Neurological Outpatients Evaluated over 20 Years in Guayaquil, Ecuador.NUEVO

Del Brutto OH, Del Brutto VJ.
Neurol Int. 2013 Aug 20;5(3):e18. doi: 10.4081/ni.2013.e18.
Pub MED

[Rehabilitation of post-stroke patients with movement disorders].NUEVO

Markin SP.
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(9 Pt 2):59-61. Russian. No abstract available.
Pub MED

Coding for the use of botulinum toxin for movement disorders.NUEVO

Brashear A, Bushong L.
Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1406-15. doi: 10.1212/01.CON.0000436164.71565.c5. No abstract available.
Pub MED

Video recording in movement disorders: practical issues.NUEVO

Duker AP.
Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1401-5. doi: 10.1212/01.CON.0000436163.63941.d6.
Pub MED

Psychogenic movement disorders.NUEVO

Morgante F, Edwards MJ, Espay AJ.
Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1383-96. doi: 10.1212/01.CON.0000436160.41071.79. Review.
Pub MED

Spontaneously hypertensive rats: possible animal model of sleep-related movement disorders.NUEVO

Esteves AM, Lopes C, Frussa-Filho R, Frank MK, Cavagnolli D, Arida RM, Tufik S, de Mello MT.
J Mot Behav. 2013;45(6):487-93. doi: 10.1080/00222895.2013.833079.
Pub MED

Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies.NUEVO

Bolgár B, Arany Á, Temesi G, Balogh B, Antal P, Mátyus P.
Curr Top Med Chem. 2013;13(18):2337-63. Review.
Pub MED

Imaging psychogenic movement disorders.NUEVO

Mehta AR, Rowe JB, Schrag AE.
Curr Neurol Neurosci Rep. 2013 Nov;13(11):402. doi: 10.1007/s11910-013-0402-z. Review.
Pub MED

The evolving role of diffusion magnetic resonance imaging in movement disorders.NUEVO

Hess CW, Ofori E, Akbar U, Okun MS, Vaillancourt DE.
Curr Neurol Neurosci Rep. 2013 Nov;13(11):400. doi: 10.1007/s11910-013-0400-1. Review.
Pub MED

The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.NUEVO

Hayhow BD, Hassan I, Looi JC, Gaillard F, Velakoulis D, Walterfang M.
Tremor Other Hyperkinet Mov (N Y). 2013 Aug 26;3. pii: tre-03-175-4242-1. doi: 10.7916/D8SN07PK.
Pub MED

Nonhuman primates: translational models for predicting antipsychotic-induced movement disorders.NUEVO

Porsolt RD, Castagné V, Hayes E, Virley D.
J Pharmacol Exp Ther. 2013 Dec;347(3):542-6. doi: 10.1124/jpet.113.207209. Review.
Pub MED

Diagnostic challenges in movement disorders: Sensory Ataxia Neuropathy Dysarthria and Ophthalmoplegia (SANDO) syndrome.NUEVO

Lovan A, Ihtsham ul Haq, Balakrishnan N.
BMJ Case Rep. 2013 Aug 30;2013. pii: bcr2013010343. doi: 10.1136/bcr-2013-010343.
Pub MED

Imaging the role of GABA in movement disorders.NUEVO

Boecker H.
Curr Neurol Neurosci Rep. 2013 Oct;13(10):385. doi: 10.1007/s11910-013-0385-9. Review.
Pub MED

Current world literature. Movement disorders.NUEVO

[No authors listed]
Curr Opin Neurol. 2013 Aug;26(4):451-5. No abstract available.
Pub MED

The current state and needs of north american movement disorders fellowship programs.NUEVO

Shih LC, Tarsy D, Okun MS.
Parkinsons Dis. 2013;2013:701426. doi: 10.1155/2013/701426.
Pub MED

Announcing a new continuing medical education course: “Bridging Neurology and Psychiatry: Movement Disorders”.NUEVO

Friedman JH.
Cogn Behav Neurol. 2013 Jun;26(2):56-8. No abstract available.
Pub MED

Episodic movement disorders: from phenotype to genotype and back.NUEVO

Brockmann K.
Curr Neurol Neurosci Rep. 2013 Oct;13(10):379. doi: 10.1007/s11910-013-0379-7. Review.
Pub MED

Effect of Hypericum perforatum on different models of movement disorders in rats.NUEVO

Reis EM, Röpke J, Busanello A, Reckziegel P, Leal CQ, Wagner C, Boligon AA, Athayde ML, Fachinetto R.
Behav Pharmacol. 2013 Oct;24(7):623-7. doi: 10.1097/FBP.0b013e3283656d68.
Pub MED

Complex movement disorders in fatal familial insomnia: a clinical and genetic discussion.NUEVO

Pedroso JL, Pinto WB, Souza PV, Ricarte IF, Landemberger MC, Martins VR, Prado LB, Prado GF, Barsottini OG.
Neurology. 2013 Sep 17;81(12):1098-9. doi: 10.1212/WNL.0b013e3182a4a41d. No abstract available.
Pub MED

Deep brain stimulation in nonparkinsonian movement disorders and emerging technologies, targets, and therapeutic promises in deep brain stimulation.NUEVO

Anderson D, Kartha N.
Neurol Clin. 2013 Aug;31(3):809-26. doi: 10.1016/j.ncl.2013.03.008. Review.
Pub MED

Movement disorders: novel FUS gene variants linked to essential tremor.NUEVO

Wood H.
Nat Rev Neurol. 2013 Aug;9(8):418. doi: 10.1038/nrneurol.2013.143. No abstract available.
Pub MED

Complementary therapies in hemifacial spasm and comparison with other movement disorders.NUEVO

Peeraully T, Hameed S, Cheong PT, Pavanni R, Hussein K, Fook-Chong SM, Tan EK.
Int J Clin Pract. 2013 Aug;67(8):801-6. doi: 10.1111/ijcp.12151. Review.
Pub MED

The clinical effects of deep brain stimulation of the pedunculopontine tegmental nucleus in movement disorders may not be related to the anatomical target, leads location, and setup of electrical stimulation.NUEVO

Mazzone P, Sposato S, Insola A, Scarnati E.
Neurosurgery. 2013 Nov;73(5):894-906; discussion 905-6. doi: 10.1227/NEU.0000000000000108.
Pub MED

[Development of movement disorders in DBA/2J male mice under repeated experience of aggression].NUEVO

Vishnivetskaia GB, Avgustinovich DF, Kudriavtseva NN.
Zh Vyssh Nerv Deiat Im I P Pavlova. 2013 Mar-Apr;63(2):235-45. Russian.
Pub MED

Acute complications of movement disorders surgery: effects of age and comorbidities.NUEVO

Rughani AI, Hodaie M, Lozano AM.
Mov Disord. 2013 Oct;28(12):1661-7. doi: 10.1002/mds.25610.
Pub MED

The management of osteoarthritis in movement disorders: a case discussion.NUEVO

Stafford GH, Howard RS, Lavelle J.
Tremor Other Hyperkinet Mov (N Y). 2013 Jul 11;3. pii: tre-03-153-3642-4. doi: 10.7916/D8MW2FVX.
Pub MED

Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders.NUEVO

Sharma S, Kumar K, Deshmukh R, Sharma PL.
Eur J Pharmacol. 2013 Aug 15;714(1-3):486-97. doi: 10.1016/j.ejphar.2013.06.038. Review.
Pub MED

The Movement Disorders Society criteria for the diagnosis of Parkinson's disease dementia: their usefulness and limitations in elderly patients.NUEVO

Kiesmann M, Chanson JB, Godet J, Vogel T, Schweiger L, Chayer S, Kaltenbach G.
J Neurol. 2013 Oct;260(10):2569-79. doi: 10.1007/s00415-013-7018-8.
Pub MED

Neurobiology of functional (psychogenic) movement disorders.NUEVO

Edwards MJ, Fotopoulou A, Pareés I.
Curr Opin Neurol. 2013 Aug;26(4):442-7. doi: 10.1097/WCO.0b013e3283633953. Review.
Viendo del 1 al 40 de 116 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.